Barabara Kotei

Ahead of an expected uptick in news flow next month, Credit Suisse reviewed its ratings and price targets on the shares of several pharma companies, keeping in mind the fiscal year 2017 and the first-half of 2018. The firm downgraded shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:...